Latest Industry Insights
Industry Insight
New Developments in Analytical Systems May Aid the “Fight” Against PFAS
Technology Networks recently spoke with Dr. Holly Lee and Dr. Craig Butt from SCIEX to learn more about the analytical challenges of detecting PFAS and SCIEX’s 7500+ system to aid developments in mass spectrometry.
Industry Insight
New Biobased Film Aids Sustainability Challenges Within the Biopharma Industry
We sat down with Dr. John Puglia, senior director of research and development at Thermo Fisher, to learn more about their new biobased films and other sustainability initiatives.
Industry Insight
Understanding Doping Control in Sports: An Interview With Professor Peter Van Eenoo
We sat down with Professor Peter Van Eenoo, director of the Doping Control Laboratory (DoCoLab), part of the University of Ghent, Belgium, to discuss the intricacies of anti-doping testing and the challenges faced in catching sporting cheats.
Industry Insight
How New Technology Can Leverage Single-Cell Omics Techniques
In this interview, we spoke to Jason Koth, product management lead at Scale Biosciences, to learn more about their new ScalePlex technology for leveraging and overcoming current limitations within single-cell genomics.
Industry Insight
The Adoption of AI: Critical Concerns in the Life Sciences
In this interview, Dr. Becky Upton discusses the key findings of a recent survey conducted by the Pistoia Alliance regarding the use of AI in life sciences and the main hurdles preventing wider adoption of AI in pharma.
Industry Insight
Next Generation Precision Genome Editing: Combining Multiple Advances To Create Safer Gene Therapies
In this article, Michelle Fraser and Amanda Haupthow discuss how engineered nucleases in combination with next-generation base editing platforms are paving the way for the development of novel treatments for genetic disorders and diseases.
Industry Insight
Attacking Cancer Through Activating “Big Eaters” of the Immune System
In this interview, Technology Networks spoke with Dr. Roy Maute, co-founder and CEO of Pheast Therapeutics, to learn about macrophage checkpoint therapies and the potential they hold for cancer treatment.
Industry Insight
Harnessing AI and Automation for the Future of Drug Discovery
In this interview, Tola Olorunnisola, senior vice president and general manager at Avantor, delves into how AI and automation could put the Lab of the Future within our grasp, enabling scientific breakthroughs and revolutionizing the drug development process.
Industry Insight
Leveraging Proteomics for Clinical Biomarker Discovery
In this article, Asim Siddiqui explores the emerging ability of proteomics to reveal new biomarkers for disease.
Industry Insight
Meeting Complex Biopharma Analytical Needs
In this interview, Technology Networks spoke to Dr. Martin Vollmer, biopharma program manager within the Life Science Analysis Group at Agilent, to learn about the current analytical challenges the biopharma industry faces and how they are being addressed.
Advertisement
